Product
Assessment of the Predictive Value of ctDNA Level of the Prominent Mutant Allele Variation
1 clinical trial
1 indication
Indication
NSCLCClinical trial
LIquid Biopsy to prEdict Responses To First-line immunotherapY in Metastatic Non-small Cell LUNG CancerStatus: Recruiting, Estimated PCD: 2024-10-09